Sun Pharmaceutical Industries Ltd.

BSE: 524715 | NSE: SUNPHARMA
Large Cap | Pharmaceuticals & Drugs
1612.55
0.55 (0.03%)
< Home < Back

Sun Pharma gets USFDA’s nod for Oxymorphone Hydrochloride

Date: 30-04-2015

Sun Pharmaceutical Industries has received US Food and Drugs Administration’s (USFDA) approval for a painkiller tablet called ‘Oxymorphone Hydrochloride’. Including this medicine, the company has received total seven approvals from US FDA in last one year, these medicine are- Oxymorphone Hydrochloride, Fesoterodine Fumarate, Opcicon One-step, Clonazepam, Clonidine Hydrochloride, Hydrochlorothiazide and Furosemide.

Sun Pharmaceutical Industries is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, US and several other markets across the world.